Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Biotransformation of l-CysteineS-Conjugates andN-Acetyl-l-CysteineS-Conjugates of the Sevoflurane Degradation Product Fluoromethyl-2,2-Difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Human Kidney in Vitro: Interindividual Variability inN-Acetylation, N-Deacetylation, and β-Lyase-Catalyzed Metabolism

T. Gul Altuntas and Evan D. Kharasch
Drug Metabolism and Disposition February 2002, 30 (2) 148-154; DOI: https://doi.org/10.1124/dmd.30.2.148
T. Gul Altuntas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan D. Kharasch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 30 no. 2 148-154
DOI 
https://doi.org/10.1124/dmd.30.2.148
PubMed 
11792683

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received July 17, 2001
  • Accepted November 9, 2001
  • Published online February 1, 2002.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. T. Gul Altuntas1 and
  2. Evan D. Kharasch1,2
  1. 1Department of Anesthesiology (T.G.A., E.D.K.) and 2Department of Medicinal Chemistry (E.D.K.), University of Washington, Seattle, Washington
  1. Professor Evan D. Kharasch, Department of Anesthesiology, University of Washington, Box 356540, Seattle, WA 98195. E-mail: kharasch{at}u.washington.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to September 2023

AbstractFullPdf
Aug 20170112
Sep 20170195
Oct 201711114
Nov 20172113
Dec 2017183
Jan 2018090
Feb 20181136
Mar 20180126
Apr 20180223
May 20180134
Jun 20182153
Jul 20180114
Aug 2018082
Sep 2018093
Oct 2018064
Nov 2018074
Dec 2018632
Jan 2019600
Feb 20191533
Mar 20191300
Apr 2019810
May 20191000
Jun 2019502
Jul 2019600
Aug 20191211
Oct 2019511
Nov 2019911
Dec 20191900
Jan 20201900
Feb 20201034
Mar 20202800
May 20202800
Jun 20202620
Jul 2020800
Aug 20202703
Sep 20203511
Oct 20202600
Nov 20201451
Dec 20201000
Jan 20211710
Feb 2021710
Mar 2021930
Apr 20211121
May 20211032
Jun 2021810
Jul 2021920
Aug 2021710
Sep 20211021
Oct 20211110
Nov 20216110
Dec 20213110
Jan 20221810
Feb 20221211
Mar 20221510
Apr 2022410
May 2022910
Jun 20221810
Jul 20221210
Aug 20221121
Sep 20221010
Oct 20221310
Nov 2022810
Dec 2022721
Jan 20231610
Feb 20231220
Mar 2023711
Apr 20232620
May 20231410
Jun 20232910
Jul 20231610
Aug 2023510
Sep 2023810

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 30 (2)
Drug Metabolism and Disposition
Vol. 30, Issue 2
1 Feb 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Biotransformation of l-CysteineS-Conjugates andN-Acetyl-l-CysteineS-Conjugates of the Sevoflurane Degradation Product Fluoromethyl-2,2-Difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Human Kidney in Vitro: Interindividual Variability inN-Acetylat…
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Biotransformation of l-CysteineS-Conjugates andN-Acetyl-l-CysteineS-Conjugates of the Sevoflurane Degradation Product Fluoromethyl-2,2-Difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Human Kidney in Vitro: Interindividual Variability inN-Acetylation, N-Deacetylation, and β-Lyase-Catalyzed Metabolism

T. Gul Altuntas and Evan D. Kharasch
Drug Metabolism and Disposition February 1, 2002, 30 (2) 148-154; DOI: https://doi.org/10.1124/dmd.30.2.148

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Biotransformation of l-CysteineS-Conjugates andN-Acetyl-l-CysteineS-Conjugates of the Sevoflurane Degradation Product Fluoromethyl-2,2-Difluoro-1-(trifluoromethyl)vinyl Ether (Compound A) in Human Kidney in Vitro: Interindividual Variability inN-Acetylation, N-Deacetylation, and β-Lyase-Catalyzed Metabolism

T. Gul Altuntas and Evan D. Kharasch
Drug Metabolism and Disposition February 1, 2002, 30 (2) 148-154; DOI: https://doi.org/10.1124/dmd.30.2.148
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • IVIVE of aldehyde oxidase-mediated clearance
  • ALTBio Consortium developed for drug metabolism research.
  • Ontogeny of CPPGL
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics